Why is aap Implantate AG ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-7.69%
EBIT Growth (5y)
12.45%
EBIT to Interest (avg)
-4.74
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.89
Tax Ratio
0.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.31
EV to EBIT
-13.83
EV to EBITDA
-21.65
EV to Capital Employed
2.32
EV to Sales
1.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.77%
ROE (Latest)
-17.11%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for aap Implantate AG
Operating Cash Flow - Annually
Highest at EUR -2.13 MM and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (EUR MM)
Profit After Tax (PAT) - Quarterly
Highest at EUR -1 MM. and Grown
in each of the last 5 periodsMOJO Watch
Near term PAT trend is very positive
PAT (EUR MM)
Cash and Cash Equivalents - Half Yearly
Highest at EUR 1.40 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents (EUR MM)






